Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › TELA

SILVERARC CAPITAL MANAGEMENT, LLC position in TELA

TELA BIO INC · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 2,137,201 shares of TELA (TELA BIO INC) in its Q3 2026 13F filing — a position valued at US$2.5M, representing 0.31% of its reported portfolio and ranking #49 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed TELA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.14M sh
Reported value held$2.46M
Portfolio Weight0.31%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's TELA position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in TELA in Q3 2023 at 490,471 shares (US$3.9M). The position peaked in Q4 2024 at 3,065,649 shares, worth US$9.3M. Across 13 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 2,137,201 shares valued at US$2.5M. Notable position changes include a 62% increase in Q4 2023 (shares fell 14% over the following quarter), a 29% increase in Q2 2024 (shares fell 46% over the following quarter), a 173% increase in Q4 2024 (shares fell 60% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 490.47K $3.92M New
Q4 2023 795.08K $5.26M Add
Q1 2024 776.85K $4.40M Reduce
Q2 2024 1.00M $4.70M Add
Q3 2024 1.12M $2.85M Add
Q4 2024 3.07M $9.26M Add
Q1 2025 2.77M $3.38M Reduce
Q2 2025 2.78M $5.39M Hold
Q3 2025 2.78M $4.15M Hold
Q4 2025 2.65M $3.12M Reduce
Q1 2026 2.26M $1.40M Reduce
Q2 2026 2.14M $1.60M Reduce
Q3 2026 2.14M $2.46M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TELA and 13F data

TELA (TELA BIO INC) is a Health Care company. 16 other funds we track also report a position in TELA — the largest reported positions include Essex Woodlands Management, Inc. (US$8.9M), PERKINS CAPITAL MANAGEMENT INC (US$2.4M), Stonepine Capital Management, LLC (US$2.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TELA

All TELA fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held TELA?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed TELA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in TELA?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 2.14M shares of TELA (TELA BIO INC), valued at $2.46M, representing 0.31% of its reported portfolio and ranking #49.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling TELA?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC held unchanged its position in TELA. The position peaked in Q4 2024 at 3.07M shares.

Which other funds hold TELA?

Other major institutional holders of TELA include Essex Woodlands Management, Inc., PERKINS CAPITAL MANAGEMENT INC, Stonepine Capital Management, LLC, among 16 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.